Table 2.
Baseline and tumor characteristics of study participants.
| Characteristic | All participants | Hawaiian (N = 5) | Japanese (N = 10) |
|---|---|---|---|
| N (%) | N (%) | N (%) | |
| Sex | |||
| Female | 6 (40.0%) | 3 (60.0%) | 3 (30.0%) |
| Male | 9 (60.0%) | 2 (40.0%) | 7 (70.0%) |
| Age group | |||
| < 65 years | 5 (33.3%) | 3 (60.0%) | 2 (20.0%) |
| 65+ years | 10 (66.7%) | 2 (40.0%) | 8 (80.0%) |
| Cancer stage at diagnosis | |||
| Localized | 7 (46.7%) | 2 (40.0%) | 5 (50.0%) |
| Regional | 4 (26.7%) | 2 (40.0%) | 2 (20.0%) |
| Distant | 4 (26.7%) | 1 (20.0%) | 3 (30.0%) |
| Cancer grade at diagnosis | |||
| Moderately differentiated | 10 (66.7%) | 3 (60.0%) | 7 (70.0%) |
| Poorly differentiated | 3 (20.0%) | 2 (40.0%) | 1 (10.0%) |
| Unknown | 2 (13.3%) | 0 (13.3%) | 2 (20.0%) |
| Chemotherapy | |||
| Yes | 7 (46.7%) | 2 (40.0%) | 5 (50.0%) |
| No/unknown | 8 (53.3%) | 3 (60.0%) | 5 (50.0%) |
| Radiation treatment | |||
| Yes | 5 (33.3%) | 2 (40.0%) | 3 (30.0%) |
| No/unknown | 10 (66.7%) | 3 (60.0%) | 7 (70.0%) |